Abstract:The clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein 9 (Cas9) system, an RNA-guided nuclease for specific genome editing in vivo, has been adopted in a wide variety of organisms. In contrast, the in vitro application of the CRISPR/Cas9 system has rarely been reported. We present here a highly efficient in vitro CRISPR/Cas9-mediated editing (ICE) system that allows specific refactoring of biosynthetic gene clusters in Streptomyces bacteria and other large DNA fragments. Cleavage by Cas9 of circular pUC18 DNA was investigated here as a simple model, revealing that the 3'→5' exonuclease activity of Cas9 generates errors with 5 to 14 nucleotides (nt) randomly missing at the editing joint. T4 DNA polymerase was then used to repair the Cas9-generated sticky ends, giving substantial improvement in editing accuracy. Plasmid pYH285 and cosmid 10A3, harboring a complete biosynthetic gene cluster for the antibiotics RK-682 and holomycin, respectively, were subjected to the ICE system to delete the rkD and homE genes in frame. Specific insertion of the ampicillin resistance gene (bla) into pYH285 was also successfully performed. These results reveal the ICE system to be a rapid, seamless, and highly efficient way to edit DNA fragments, and a powerful new tool for investigating and engineering biosynthetic gene clusters. Importance: Recent improvements in cloning strategies for biosynthetic gene clusters promise rapid advances in understanding and exploiting natural products in the environment. For manipulation of such biosynthetic gene clusters to generate valuable bioactive compounds, efficient and specific gene editing of these large DNA fragments is required. In this study, a highly efficient in vitro DNA editing system has been established. When combined with end repair using T4 DNA polymerase, Cas9 precisely and seamlessly catalyzes targeted editing, including in-frame deletion or insertion of the gene(s) of interest. This in vitro CRISPR editing (ICE) system promises a step forward in our ability to engineer biosynthetic pathways.

Deaminase-mediated multiplex genome editing in Escherichia coli

[Optimization of CRISPR/Cas9-based multiplex base editing in Corynebacterium glutamicum].

Multigene Editing in the Escherichia coli Genome via the CRISPR-Cas9 System

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

CRISPR/Cas9 assisted Multiplex Genome Editing Technique in Escherichia coli.

Highly Efficient Base Editing in Bacteria Using a Cas9-cytidine Deaminase Fusion

Multiplex Genome Editing Using a Dcas9-Cytidine Deaminase Fusion in Streptomyces

CRISPR-Assisted Multiplex Base Editing System in Pseudomonas putida KT2440

Expanding targeting scope, editing window, and base transition capability of base editing in Corynebacterium glutamicum.

Multiplex Gene Disruption by Targeted Base Editing of Yarrowia lipolytica Genome Using Cytidine Deaminase Combined with the CRISPR/Cas9 System

A versatile genetic engineering toolkit for E. coli based on CRISPR-prime editing

Base editing enables duplex point mutagenesis in Clostridium autoethanogenum at the price of numerous off-target mutations

CRISPR/Cas9-deaminase Enables Robust Base Editing in Rhodobacter Sphaeroides 2.4.1

A Multiplex Genome Editing Method for Escherichia coli Based on CRISPR-Cas12a.

Combining CRISPR-Cpf1 and Recombineering Facilitates Fast and Efficient Genome Editing in Escherichia coli

Efficient CRISPR-Cas9 based cytosine base editors for phytopathogenic bacteria

In Vitro CRISPR/Cas9 System for Efficient Targeted DNA Editing

A modified pCas/pTargetF system for CRISPR-Cas9-assisted genome editing in Escherichia coli

Chemical transformation mediated CRISPR/Cas9 genome editing in Escherichia coli

Base editing in Streptomyces with Cas9 deaminase fusions

Bacterial genome editing by coupling Cre-lox and CRISPR-Cas9 systems